ATAI
Price
$2.20
Change
-$0.05 (-2.22%)
Updated
Jun 27 closing price
Capitalization
461.53M
51 days until earnings call
VTGN
Price
$1.97
Change
-$0.08 (-3.90%)
Updated
Jun 27 closing price
Capitalization
57.44M
Interact to see
Advertisement

ATAI vs VTGN

Header iconATAI vs VTGN Comparison
Open Charts ATAI vs VTGNBanner chart's image
ATAI Life Sciences
Price$2.20
Change-$0.05 (-2.22%)
Volume$965.63K
Capitalization461.53M
VistaGen Therapeutics
Price$1.97
Change-$0.08 (-3.90%)
Volume$222.36K
Capitalization57.44M
ATAI vs VTGN Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. VTGN commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ATAI: $2.19 vs. VTGN: $1.97)
Brand notoriety: ATAI and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 42% vs. VTGN: 143%
Market capitalization -- ATAI: $461.53M vs. VTGN: $57.44M
ATAI [@Biotechnology] is valued at $461.53M. VTGN’s [@Biotechnology] market capitalization is $57.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 5 bullish, 3 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than VTGN.

Price Growth

ATAI (@Biotechnology) experienced а -11.69% price change this week, while VTGN (@Biotechnology) price change was -1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

VTGN is expected to report earnings on Jun 17, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($462M) has a higher market cap than VTGN($57.4M). ATAI YTD gains are higher at: 64.662 vs. VTGN (-33.220). VTGN has higher annual earnings (EBITDA): -52.22M vs. ATAI (-145.09M). ATAI has more cash in the bank: 98.2M vs. VTGN (88.6M). VTGN has less debt than ATAI: VTGN (1.71M) vs ATAI (26.7M). ATAI has higher revenues than VTGN: ATAI (1.86M) vs VTGN (698K).
ATAIVTGNATAI / VTGN
Capitalization462M57.4M805%
EBITDA-145.09M-52.22M278%
Gain YTD64.662-33.220-195%
P/E RatioN/AN/A-
Revenue1.86M698K267%
Total Cash98.2M88.6M111%
Total Debt26.7M1.71M1,559%
FUNDAMENTALS RATINGS
ATAI vs VTGN: Fundamental Ratings
ATAI
VTGN
OUTLOOK RATING
1..100
6755
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
46
Fair valued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
3788
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
12n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (46) in the Biotechnology industry is in the same range as ATAI (67) in the Miscellaneous Commercial Services industry. This means that VTGN’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Profit vs Risk Rating (96) in the Miscellaneous Commercial Services industry is in the same range as VTGN (100) in the Biotechnology industry. This means that ATAI’s stock grew similarly to VTGN’s over the last 12 months.

VTGN's SMR Rating (96) in the Biotechnology industry is in the same range as ATAI (98) in the Miscellaneous Commercial Services industry. This means that VTGN’s stock grew similarly to ATAI’s over the last 12 months.

ATAI's Price Growth Rating (37) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for VTGN (88) in the Biotechnology industry. This means that ATAI’s stock grew somewhat faster than VTGN’s over the last 12 months.

ATAI's P/E Growth Rating (14) in the Miscellaneous Commercial Services industry is significantly better than the same rating for VTGN (100) in the Biotechnology industry. This means that ATAI’s stock grew significantly faster than VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATAIVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZEUS33.020.55
+1.69%
Olympic Steel
WKC28.170.02
+0.07%
World Kinect Corp
ISRG533.71-0.48
-0.09%
Intuitive Surgical
REFR1.66-0.01
-0.60%
Research Frontiers
CACC502.66-6.04
-1.19%
Credit Acceptance Corp

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-2.67%
MNMD - ATAI
54%
Loosely correlated
-2.67%
RXRX - ATAI
46%
Loosely correlated
-6.94%
CYBN - ATAI
46%
Loosely correlated
-5.01%
COUR - ATAI
45%
Loosely correlated
+1.39%
VCYT - ATAI
45%
Loosely correlated
+2.13%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.90%
ABOS - VTGN
47%
Loosely correlated
-5.37%
RNA - VTGN
42%
Loosely correlated
-2.68%
IMNM - VTGN
41%
Loosely correlated
-0.11%
ATAI - VTGN
41%
Loosely correlated
-2.67%
TRDA - VTGN
41%
Loosely correlated
-1.57%
More